10,000 results · 61ms · Sources: EU EUDAMED, US FDA

SenoRx Inc.

FDA registration
INFUS MEDICAL (THAILAND) CO., LTD.·1 product·🇹🇭 Thailand

SenoRx

FDA registration
INFUS MEDICAL (THAILAND) CO., LTD.·1 product·🇹🇭 Thailand

TITANIUM HEMOSTATIC CLIP

FDA registration
INFUS MEDICAL (THAILAND) CO., LTD.·1 product·🇹🇭 Thailand

Bosma Enterprises

FDA UDI
Bosma Enterprises·00818634020901·Hygiene Kit; Each Kit Includes Comb, 2 oz Mouth...

CER-SUB-1111-OT-BNT

FDA UDI
RANFAC CORP.·00850023741196·Cervos 11GA X 11" Delivery Cannula, Open Tip, W...

CER-SUB-1111-OT-BNT

FDA UDI
RANFAC CORP.·00850023741387·CER-SUB-1111-OT-BNT PN: 74387-01M

System, Test, Her-2/Neu, Ihc

FDA Pre-Market Approval
FDA Class 3 ·PATHWAY ANTI-HER-2/NEU (4B5) PRIMARY ANTIBODY

System, Test, Her-2/Neu, Ihc

FDA Pre-Market Approval
FDA Class 3 ·PATHWAY HER-2/NEU (CLONE CB11) PRIMARY ANTIBODY

System, Test, Her-2/Neu, Nucleic Acid Or Serum

FDA Pre-Market Approval
FDA Class 3 ·THE PATH VYSION HER-2 DNA PRODE KIT

Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer

FDA Pre-Market Approval
FDA Class 3 ·INFORM HER-2 DUAL ISH DNA PROBE COCKTAIL

Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer

FDA Pre-Market Approval
FDA Class 3 ·INFORM HER-2 DUAL ISH DNA PROBE COCKTAIL

System, Test, Her-2/Neu, Nucleic Acid Or Serum

FDA Pre-Market Approval
FDA Class 3 ·PATH VYSION HER-2 DNA PROBE KIT ASSAY

System, Test, Her-2/Neu, Ihc

FDA Pre-Market Approval
FDA Class 3 ·PATHWAY HER-2/NEU (CLONE CD11) PRIMARY ANTIBODY

Intraocular Lens

FDA Pre-Market Approval
FDA Class 3 ·PHACOFLEX II(R) SILICONE POSTERIOR CHAMBER INTRAOCULAR LENS

System, Test, Her-2/Neu, Nucleic Acid Or Serum

FDA Pre-Market Approval
FDA Class 3 ·PATH VYSION HER-2 DNA PROBE KIT ASSAY

System, Test, Her-2/Neu, Nucleic Acid Or Serum

FDA Pre-Market Approval
FDA Class 3 ·VYSIS PATH VYSION HER-2 DNA PROBE KIT

Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer

FDA Pre-Market Approval
FDA Class 3 ·INFORM HER-2 DUAL ISH DNA PROBE COCKTAIL

Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer

FDA Pre-Market Approval
FDA Class 3 ·INFORM HER-2 DUAL ISH DNA PROBE COCKTAIL

Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer

FDA Pre-Market Approval
FDA Class 3 ·INFORM HER-2 DUAL ISH DNA PROBE COCKTAIL

Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer

FDA Pre-Market Approval
FDA Class 3 ·INFORM HER-2 DUAL ISH DNA PROBE COCKTAIL